We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher. In this article, we are ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...

Research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Merck & Co., Inc. in a report released ...

Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of Merck & Co., Inc. in a research note issued to investors on Tuesday, April 1st. Zacks Research analyst S. Ganoria ...

Merck & Company has an analyst consensus of Moderate Buy, with a price target consensus of $111.88, a 25.38% upside from current levels. In a report released on March 28, Leerink Partners also ...

Hengrui Pharma signs exclusive licensing agreement for its heart disease drug with Merck & Co.

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in an increasingly complex landscape.

MSD Animal Health UK Limited, a subsidiary of Merck & Co, has launched the enzootic abortion (EAE) testing phase of its 2025 FlockCheck scheme. Sheep farmers in England, Scotland, and Wales can now ...

Senator, Dr. Rasha Kelej, CEO of Merck Foundation and One of the Most Influential African Women for Six Consecutive Years ...

RAHWAY, N.J., April 01, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire ...